Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of February 24, 2025, the Company's portfolio consisted of 97 assets, 53 of which are wholly owned, with a total of 14,553 guestrooms located in 25 states.

Summit Hotel Properties, Inc.

An update from InnovAge Holding ( ($INNV) ) is now available. On September 22, 2026, InnovAge Holding Corp. entered an underwriting agreement with ...

InnovAge Holding Completes Major Secondary Stock Offering

InnoCan Pharma ( ($TSE:INNO) ) has shared an announcement. Innocan Pharma has closed the first tranche of a private placement, issuing 247,314 unit...

Innocan Pharma Raises C$462,477 in First Tranche of Unit Offering

Jefferies analyst Miruna Chirea maintained a Hold rating on ING GROEP yesterday. The company’s shares closed last Thursday at €31.72. According to ...

Jefferies Sticks to Its Hold Rating for ING GROEP (0RIC)

Mizuho Securities analyst Yaron Kinar maintained a Hold rating on American International Group yesterday and set a price target of $85.00. The comp...

Mizuho Securities Remains a Hold on American International Group (AIG)

An announcement from Amplia Therapeutics ( ($AU:ATX) ) is now available. Amplia Therapeutics said Chief Executive Officer and Managing Director Dr ...

Amplia Showcases FAK Oncology Pipeline at E&P Healthcare Conference

Innovage Holding Corp. (($INNV)) has held its Q4 earnings call. Read on for the main highlights of the call. InnovAge Holding Corp. struck an upbea...

InnovAge Holding Corp. Signals Breakout Year in Earnings

An update from ING GROEP ( ($NL:INGA) ) is now available. ING Groep has reported further progress on its €1.0 billion share buyback programme, repu...

ING nears three-quarters completion of €1 billion share buyback

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY), Stryker (SYK) and Inno...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

KeyBanc analyst Matthew Gillmor CFA maintained a Buy rating on InnovAge Holding today and set a price target of $14.00. Gillmor CFA covers the Heal...

InnovAge Holding (INNV) Receives a Buy from KeyBanc

In a report released today, Delphine Lee from J.P. Morgan maintained a Buy rating on ING GROEP, with a price target of €36.30. According to TipRank...

ING GROEP (0RIC) Gets a Buy from J.P. Morgan

InnoCan Pharma ( ($TSE:INNO) ) has shared an update. Innocan Pharma reported second-quarter fiscal 2026 revenue of US$5.25 million, down 25% year o...

Innocan Pharma Q2 Revenue Falls but High Margins and Amazon Leadership Support Expansion Push

Huatai Securities analyst maintained a Buy rating on Qfin Holdings yesterday and set a price target of HK$53.00. The company’s shares closed yester...

Huatai Securities Remains a Buy on Qfin Holdings (3660)

The latest update is out from Amplia Therapeutics ( ($AU:ATX) ). Amplia Therapeutics said all resolutions at its 28 August annual general meeting w...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INN	$5.74	+0.35%	854.62K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INN	$5.74	+0.3%	854.62K
3
4
5
6

INN

Get Summit Hotel Properties, Inc. Data in Excel

Get Summit Hotel Properties, Inc. Data in Excel